- 期刊
再生醫學新興產業發展技術法規影響與探討
Impact of Technical Regulations on the Development of Emerging Industries of Regenerative Medicine
摘要
新興產業的發展代表了科技、市場需求和社會變革的交互作用。新興產業通常以創新性、高增長和高風險為特徵，它們在相對短的時間內崛起，改變了商業和社會的面貌。再生醫學是新興產業，旨在利用生物學原理和工程技術來恢復和改進受損組織和器官的功能。傳統的醫療方法主要集中在疾病的症狀治療，而再生醫學的目標是修復和替換損傷的組織，實現真正的治癒，也是醫學上的突破與解決方案。先進SVF幹細胞技術則提供了一個強大的工具與領導產業發展的核心技術。全球細胞治療法規是指各國政府和國際機構制定和實施的法律、規定和指南，監管細胞治療的開發、製造、臨床應用和商業化。為了確保細胞治療的安全性、有效性和倫理性，全球各地都制定了法規框架，來促進管理這一快速發展的領域。全球細胞治療法規的重要性不言而喻。它們確保了患者的權益和安全，防止不當的商業實踐，並鼓勵創新和科學研究的發展。
並列摘要
The development of emerging industries represents the interaction of technology, market demand and social change. Emerging industries are usually characterized by innovation, high growth and high risk. They rise in a relatively short period of time and change the face of business and society. Regenerative medicine is an emerging industry that aims to use biological principles and engineering technologies to restore and improve the function of damaged tissues and organs. Traditional medical methods mainly focus on treating the symptoms of diseases, while the goal of regenerative medicine is to repair and replace damaged tissues to achieve true cure, which is also a breakthrough and solution in medicine. Advanced SVF stem cell technology provides a powerful tool and core technology that leads industry development. Global cell therapy regulations refer to the laws, regulations and guidelines formulated and implemented by governments and international agencies to regulate the development, manufacturing, clinical application and commercialization of cell therapies. To ensure the safety, efficacy and ethics of cell therapies, regulatory frameworks have been developed around the world to facilitate the management of this rapidly evolving field. The importance of global cell therapy regulations cannot be overstated. They ensure patient rights and safety, prevent inappropriate business practices, and encourage the development of innovation and scientific research.